BiotechTubeBiotechTube
Home/Aucta Pharmaceuticals/Chris Jarman
CJ

Chris Jarman

Vice President, Managed Markets and Operations

Aucta Pharmaceuticals

Therapeutic Areas

Central Nervous System (CNS) DisordersMetabolic DiseasesOrphan and Specialty IndicationsOphthalmicsDermatologyPediatrics

Aucta Pharmaceuticals Pipeline

DrugIndicationPhase
Motpoly XR™EpilepsyNot Specified (Likely Phase 3/NDA)
CNS Pipeline CandidatesCentral Nervous System DisordersNot Specified
Orphan/Specialty Pipeline CandidatesOrphan and Specialty IndicationsNot Specified
Metabolic Disease CandidatesMetabolic DiseasesNot Specified
Ophthalmics CandidatesOphthalmicsNot Specified
Dermatology CandidatesDermatologyNot Specified
Pediatrics CandidatesPediatricsNot Specified

Leadership Team at Aucta Pharmaceuticals

SL
Shoufeng Li, Ph.D.
Chief Executive Officer, Founder, Scientist
BZ
Brian Zorn, Pharm.D.
Executive Director
QR
Qiaolin Ren, Ph.D.
Vice President
LL
Lisheng Lu
Executive Director and Vice President of Manufacture (China)
RL
Rong Li, Ph.D.
Scientific Advisor
CL
Changjun Liu
Vice President, Quality Management
LG
Lixin Gong
Head of Analysis
View full Aucta Pharmaceuticals profile